The global Halobetasol Propionate market was valued at US$ 39 million in 2023 and is anticipated to reach US$ 54 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.

Halobetasol Propionate Market

The Halobetasol Propionate market is expected to witness significant growth in the coming years due to its increasing use in the treatment of various skin conditions such as eczema, psoriasis, dermatitis, and rashes. Halobetasol Propionate is a strong corticosteroid that helps reduce itching, inflammation, redness, and swelling associated with these skin conditions.The growing prevalence of skin diseases across the globe is a major driving factor for the market. Factors such as changing lifestyles, increasing pollution levels, and exposure to harmful chemicals are leading to an increase in the incidence of skin conditions. This is creating a huge demand for halobetasol propionate-based medications.

This report aims to provide a comprehensive presentation of the global market for Halobetasol Propionate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Halobetasol Propionate.

Report Scope

The Halobetasol Propionate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Halobetasol Propionate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Halobetasol Propionate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Halobetasol Propionate Market Report

Report Metric	Details
Report Name	Halobetasol Propionate Market
Accounted market size in 2023	US$ 39 million
Forecasted market size in 2030	US$ 54 million
CAGR	4.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	15g 30g Other
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	ULTRAVATE, LEXETTE, Glenmark Pharma, Sun Pharma, BRYHALI, PERRIGO, Duobrii, STERLING, Midas Pharma, Pfizer, Taro Pharmaceuticals, Glenwood Pharmaceuticals, Fougera Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Halobetasol Propionate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Halobetasol Propionate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Halobetasol Propionate Market growing?

Ans: The Halobetasol Propionate Market witnessing a CAGR of 4.9% during the forecast period 2024-2030.

What is the Halobetasol Propionate Market size in 2030?

Ans: The Halobetasol Propionate Market size in 2030 will be US$ 54 million.

Who are the main players in the Halobetasol Propionate Market report?

Ans: The main players in the Halobetasol Propionate Market are ULTRAVATE, LEXETTE, Glenmark Pharma, Sun Pharma, BRYHALI, PERRIGO, Duobrii, STERLING, Midas Pharma, Pfizer, Taro Pharmaceuticals, Glenwood Pharmaceuticals, Fougera Pharmaceuticals

What are the Application segmentation covered in the Halobetasol Propionate Market report?

Ans: The Applications covered in the Halobetasol Propionate Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Halobetasol Propionate Market report?

Ans: The Types covered in the Halobetasol Propionate Market report are 15g, 30g, Other

1 Halobetasol Propionate Market Overview

1.1 Product Overview and Scope of Halobetasol Propionate

1.2 Halobetasol Propionate Segment by Type

1.2.1 Global Halobetasol Propionate Market Value Comparison by Type (2024-2030)

1.2.2 15g

1.2.3 30g

1.2.4 Other

1.3 Halobetasol Propionate Segment by Application

1.3.1 Global Halobetasol Propionate Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Halobetasol Propionate Market Size Estimates and Forecasts

1.4.1 Global Halobetasol Propionate Revenue 2019-2030

1.4.2 Global Halobetasol Propionate Sales 2019-2030

1.4.3 Global Halobetasol Propionate Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Halobetasol Propionate Market Competition by Manufacturers

2.1 Global Halobetasol Propionate Sales Market Share by Manufacturers (2019-2024)

2.2 Global Halobetasol Propionate Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Halobetasol Propionate Average Price by Manufacturers (2019-2024)

2.4 Global Halobetasol Propionate Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Halobetasol Propionate, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Halobetasol Propionate, Product Type & Application

2.7 Halobetasol Propionate Market Competitive Situation and Trends

2.7.1 Halobetasol Propionate Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Halobetasol Propionate Players Market Share by Revenue

2.7.3 Global Halobetasol Propionate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Halobetasol Propionate Retrospective Market Scenario by Region

3.1 Global Halobetasol Propionate Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Halobetasol Propionate Global Halobetasol Propionate Sales by Region: 2019-2030

3.2.1 Global Halobetasol Propionate Sales by Region: 2019-2024

3.2.2 Global Halobetasol Propionate Sales by Region: 2025-2030

3.3 Global Halobetasol Propionate Global Halobetasol Propionate Revenue by Region: 2019-2030

3.3.1 Global Halobetasol Propionate Revenue by Region: 2019-2024

3.3.2 Global Halobetasol Propionate Revenue by Region: 2025-2030

3.4 North America Halobetasol Propionate Market Facts & Figures by Country

3.4.1 North America Halobetasol Propionate Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Halobetasol Propionate Sales by Country (2019-2030)

3.4.3 North America Halobetasol Propionate Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Halobetasol Propionate Market Facts & Figures by Country

3.5.1 Europe Halobetasol Propionate Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Halobetasol Propionate Sales by Country (2019-2030)

3.5.3 Europe Halobetasol Propionate Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Halobetasol Propionate Market Facts & Figures by Country

3.6.1 Asia Pacific Halobetasol Propionate Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Halobetasol Propionate Sales by Country (2019-2030)

3.6.3 Asia Pacific Halobetasol Propionate Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Halobetasol Propionate Market Facts & Figures by Country

3.7.1 Latin America Halobetasol Propionate Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Halobetasol Propionate Sales by Country (2019-2030)

3.7.3 Latin America Halobetasol Propionate Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Halobetasol Propionate Market Facts & Figures by Country

3.8.1 Middle East and Africa Halobetasol Propionate Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Halobetasol Propionate Sales by Country (2019-2030)

3.8.3 Middle East and Africa Halobetasol Propionate Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Halobetasol Propionate Sales by Type (2019-2030)

4.1.1 Global Halobetasol Propionate Sales by Type (2019-2024)

4.1.2 Global Halobetasol Propionate Sales by Type (2025-2030)

4.1.3 Global Halobetasol Propionate Sales Market Share by Type (2019-2030)

4.2 Global Halobetasol Propionate Revenue by Type (2019-2030)

4.2.1 Global Halobetasol Propionate Revenue by Type (2019-2024)

4.2.2 Global Halobetasol Propionate Revenue by Type (2025-2030)

4.2.3 Global Halobetasol Propionate Revenue Market Share by Type (2019-2030)

4.3 Global Halobetasol Propionate Price by Type (2019-2030)

5 Segment by Application

5.1 Global Halobetasol Propionate Sales by Application (2019-2030)

5.1.1 Global Halobetasol Propionate Sales by Application (2019-2024)

5.1.2 Global Halobetasol Propionate Sales by Application (2025-2030)

5.1.3 Global Halobetasol Propionate Sales Market Share by Application (2019-2030)

5.2 Global Halobetasol Propionate Revenue by Application (2019-2030)

5.2.1 Global Halobetasol Propionate Revenue by Application (2019-2024)

5.2.2 Global Halobetasol Propionate Revenue by Application (2025-2030)

5.2.3 Global Halobetasol Propionate Revenue Market Share by Application (2019-2030)

5.3 Global Halobetasol Propionate Price by Application (2019-2030)

6 Key Companies Profiled

6.1 ULTRAVATE

6.1.1 ULTRAVATE Corporation Information

6.1.2 ULTRAVATE Description and Business Overview

6.1.3 ULTRAVATE Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.1.4 ULTRAVATE Halobetasol Propionate Product Portfolio

6.1.5 ULTRAVATE Recent Developments/Updates

6.2 LEXETTE

6.2.1 LEXETTE Corporation Information

6.2.2 LEXETTE Description and Business Overview

6.2.3 LEXETTE Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.2.4 LEXETTE Halobetasol Propionate Product Portfolio

6.2.5 LEXETTE Recent Developments/Updates

6.3 Glenmark Pharma

6.3.1 Glenmark Pharma Corporation Information

6.3.2 Glenmark Pharma Description and Business Overview

6.3.3 Glenmark Pharma Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Glenmark Pharma Halobetasol Propionate Product Portfolio

6.3.5 Glenmark Pharma Recent Developments/Updates

6.4 Sun Pharma

6.4.1 Sun Pharma Corporation Information

6.4.2 Sun Pharma Description and Business Overview

6.4.3 Sun Pharma Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sun Pharma Halobetasol Propionate Product Portfolio

6.4.5 Sun Pharma Recent Developments/Updates

6.5 BRYHALI

6.5.1 BRYHALI Corporation Information

6.5.2 BRYHALI Description and Business Overview

6.5.3 BRYHALI Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.5.4 BRYHALI Halobetasol Propionate Product Portfolio

6.5.5 BRYHALI Recent Developments/Updates

6.6 PERRIGO

6.6.1 PERRIGO Corporation Information

6.6.2 PERRIGO Description and Business Overview

6.6.3 PERRIGO Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.6.4 PERRIGO Halobetasol Propionate Product Portfolio

6.6.5 PERRIGO Recent Developments/Updates

6.7 Duobrii

6.6.1 Duobrii Corporation Information

6.6.2 Duobrii Description and Business Overview

6.6.3 Duobrii Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Duobrii Halobetasol Propionate Product Portfolio

6.7.5 Duobrii Recent Developments/Updates

6.8 STERLING

6.8.1 STERLING Corporation Information

6.8.2 STERLING Description and Business Overview

6.8.3 STERLING Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.8.4 STERLING Halobetasol Propionate Product Portfolio

6.8.5 STERLING Recent Developments/Updates

6.9 Midas Pharma

6.9.1 Midas Pharma Corporation Information

6.9.2 Midas Pharma Description and Business Overview

6.9.3 Midas Pharma Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Midas Pharma Halobetasol Propionate Product Portfolio

6.9.5 Midas Pharma Recent Developments/Updates

6.10 Pfizer

6.10.1 Pfizer Corporation Information

6.10.2 Pfizer Description and Business Overview

6.10.3 Pfizer Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Pfizer Halobetasol Propionate Product Portfolio

6.10.5 Pfizer Recent Developments/Updates

6.11 Taro Pharmaceuticals

6.11.1 Taro Pharmaceuticals Corporation Information

6.11.2 Taro Pharmaceuticals Halobetasol Propionate Description and Business Overview

6.11.3 Taro Pharmaceuticals Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Taro Pharmaceuticals Halobetasol Propionate Product Portfolio

6.11.5 Taro Pharmaceuticals Recent Developments/Updates

6.12 Glenwood Pharmaceuticals

6.12.1 Glenwood Pharmaceuticals Corporation Information

6.12.2 Glenwood Pharmaceuticals Halobetasol Propionate Description and Business Overview

6.12.3 Glenwood Pharmaceuticals Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Glenwood Pharmaceuticals Halobetasol Propionate Product Portfolio

6.12.5 Glenwood Pharmaceuticals Recent Developments/Updates

6.13 Fougera Pharmaceuticals

6.13.1 Fougera Pharmaceuticals Corporation Information

6.13.2 Fougera Pharmaceuticals Halobetasol Propionate Description and Business Overview

6.13.3 Fougera Pharmaceuticals Halobetasol Propionate Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Fougera Pharmaceuticals Halobetasol Propionate Product Portfolio

6.13.5 Fougera Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Halobetasol Propionate Industry Chain Analysis

7.2 Halobetasol Propionate Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Halobetasol Propionate Production Mode & Process

7.4 Halobetasol Propionate Sales and Marketing

7.4.1 Halobetasol Propionate Sales Channels

7.4.2 Halobetasol Propionate Distributors

7.5 Halobetasol Propionate Customers

8 Halobetasol Propionate Market Dynamics

8.1 Halobetasol Propionate Industry Trends

8.2 Halobetasol Propionate Market Drivers

8.3 Halobetasol Propionate Market Challenges

8.4 Halobetasol Propionate Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Fougera Pharmaceuticals

Glenwood Pharmaceuticals

List of Tables

Table 1. Global Halobetasol Propionate Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Halobetasol Propionate Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Halobetasol Propionate Market Competitive Situation by Manufacturers in 2023

Table 4. Global Halobetasol Propionate Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Halobetasol Propionate Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Halobetasol Propionate Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Halobetasol Propionate Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Halobetasol Propionate Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Halobetasol Propionate, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Halobetasol Propionate, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Halobetasol Propionate, Product Type & Application

Table 12. Global Key Manufacturers of Halobetasol Propionate, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Halobetasol Propionate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Halobetasol Propionate as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Halobetasol Propionate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Halobetasol Propionate Sales by Region (2019-2024) & (K Units)

Table 18. Global Halobetasol Propionate Sales Market Share by Region (2019-2024)

Table 19. Global Halobetasol Propionate Sales by Region (2025-2030) & (K Units)

Table 20. Global Halobetasol Propionate Sales Market Share by Region (2025-2030)

Table 21. Global Halobetasol Propionate Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Halobetasol Propionate Revenue Market Share by Region (2019-2024)

Table 23. Global Halobetasol Propionate Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Halobetasol Propionate Revenue Market Share by Region (2025-2030)

Table 25. North America Halobetasol Propionate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Halobetasol Propionate Sales by Country (2019-2024) & (K Units)

Table 27. North America Halobetasol Propionate Sales by Country (2025-2030) & (K Units)

Table 28. North America Halobetasol Propionate Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Halobetasol Propionate Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Halobetasol Propionate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Halobetasol Propionate Sales by Country (2019-2024) & (K Units)

Table 32. Europe Halobetasol Propionate Sales by Country (2025-2030) & (K Units)

Table 33. Europe Halobetasol Propionate Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Halobetasol Propionate Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Halobetasol Propionate Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Halobetasol Propionate Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Halobetasol Propionate Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Halobetasol Propionate Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Halobetasol Propionate Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Halobetasol Propionate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Halobetasol Propionate Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Halobetasol Propionate Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Halobetasol Propionate Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Halobetasol Propionate Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Halobetasol Propionate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Halobetasol Propionate Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Halobetasol Propionate Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Halobetasol Propionate Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Halobetasol Propionate Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Halobetasol Propionate Sales (K Units) by Type (2019-2024)

Table 51. Global Halobetasol Propionate Sales (K Units) by Type (2025-2030)

Table 52. Global Halobetasol Propionate Sales Market Share by Type (2019-2024)

Table 53. Global Halobetasol Propionate Sales Market Share by Type (2025-2030)

Table 54. Global Halobetasol Propionate Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Halobetasol Propionate Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Halobetasol Propionate Revenue Market Share by Type (2019-2024)

Table 57. Global Halobetasol Propionate Revenue Market Share by Type (2025-2030)

Table 58. Global Halobetasol Propionate Price (US$/Unit) by Type (2019-2024)

Table 59. Global Halobetasol Propionate Price (US$/Unit) by Type (2025-2030)

Table 60. Global Halobetasol Propionate Sales (K Units) by Application (2019-2024)

Table 61. Global Halobetasol Propionate Sales (K Units) by Application (2025-2030)

Table 62. Global Halobetasol Propionate Sales Market Share by Application (2019-2024)

Table 63. Global Halobetasol Propionate Sales Market Share by Application (2025-2030)

Table 64. Global Halobetasol Propionate Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Halobetasol Propionate Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Halobetasol Propionate Revenue Market Share by Application (2019-2024)

Table 67. Global Halobetasol Propionate Revenue Market Share by Application (2025-2030)

Table 68. Global Halobetasol Propionate Price (US$/Unit) by Application (2019-2024)

Table 69. Global Halobetasol Propionate Price (US$/Unit) by Application (2025-2030)

Table 70. ULTRAVATE Corporation Information

Table 71. ULTRAVATE Description and Business Overview

Table 72. ULTRAVATE Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. ULTRAVATE Halobetasol Propionate Product

Table 74. ULTRAVATE Recent Developments/Updates

Table 75. LEXETTE Corporation Information

Table 76. LEXETTE Description and Business Overview

Table 77. LEXETTE Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. LEXETTE Halobetasol Propionate Product

Table 79. LEXETTE Recent Developments/Updates

Table 80. Glenmark Pharma Corporation Information

Table 81. Glenmark Pharma Description and Business Overview

Table 82. Glenmark Pharma Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Glenmark Pharma Halobetasol Propionate Product

Table 84. Glenmark Pharma Recent Developments/Updates

Table 85. Sun Pharma Corporation Information

Table 86. Sun Pharma Description and Business Overview

Table 87. Sun Pharma Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Sun Pharma Halobetasol Propionate Product

Table 89. Sun Pharma Recent Developments/Updates

Table 90. BRYHALI Corporation Information

Table 91. BRYHALI Description and Business Overview

Table 92. BRYHALI Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. BRYHALI Halobetasol Propionate Product

Table 94. BRYHALI Recent Developments/Updates

Table 95. PERRIGO Corporation Information

Table 96. PERRIGO Description and Business Overview

Table 97. PERRIGO Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. PERRIGO Halobetasol Propionate Product

Table 99. PERRIGO Recent Developments/Updates

Table 100. Duobrii Corporation Information

Table 101. Duobrii Description and Business Overview

Table 102. Duobrii Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Duobrii Halobetasol Propionate Product

Table 104. Duobrii Recent Developments/Updates

Table 105. STERLING Corporation Information

Table 106. STERLING Description and Business Overview

Table 107. STERLING Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. STERLING Halobetasol Propionate Product

Table 109. STERLING Recent Developments/Updates

Table 110. Midas Pharma Corporation Information

Table 111. Midas Pharma Description and Business Overview

Table 112. Midas Pharma Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Midas Pharma Halobetasol Propionate Product

Table 114. Midas Pharma Recent Developments/Updates

Table 115. Pfizer Corporation Information

Table 116. Pfizer Description and Business Overview

Table 117. Pfizer Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Pfizer Halobetasol Propionate Product

Table 119. Pfizer Recent Developments/Updates

Table 120. Taro Pharmaceuticals Corporation Information

Table 121. Taro Pharmaceuticals Description and Business Overview

Table 122. Taro Pharmaceuticals Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Taro Pharmaceuticals Halobetasol Propionate Product

Table 124. Taro Pharmaceuticals Recent Developments/Updates

Table 125. Glenwood Pharmaceuticals Corporation Information

Table 126. Glenwood Pharmaceuticals Description and Business Overview

Table 127. Glenwood Pharmaceuticals Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Glenwood Pharmaceuticals Halobetasol Propionate Product

Table 129. Glenwood Pharmaceuticals Recent Developments/Updates

Table 130. Fougera Pharmaceuticals Corporation Information

Table 131. Fougera Pharmaceuticals Description and Business Overview

Table 132. Fougera Pharmaceuticals Halobetasol Propionate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Fougera Pharmaceuticals Halobetasol Propionate Product

Table 134. Fougera Pharmaceuticals Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Halobetasol Propionate Distributors List

Table 138. Halobetasol Propionate Customers List

Table 139. Halobetasol Propionate Market Trends

Table 140. Halobetasol Propionate Market Drivers

Table 141. Halobetasol Propionate Market Challenges

Table 142. Halobetasol Propionate Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Halobetasol Propionate

Figure 2. Global Halobetasol Propionate Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Halobetasol Propionate Market Share by Type in 2023 & 2030

Figure 4. 15g Product Picture

Figure 5. 30g Product Picture

Figure 6. Other Product Picture

Figure 7. Global Halobetasol Propionate Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Halobetasol Propionate Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Global Halobetasol Propionate Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Halobetasol Propionate Market Size (2019-2030) & (US$ Million)

Figure 14. Global Halobetasol Propionate Sales (2019-2030) & (K Units)

Figure 15. Global Halobetasol Propionate Average Price (US$/Unit) & (2019-2030)

Figure 16. Halobetasol Propionate Report Years Considered

Figure 17. Halobetasol Propionate Sales Share by Manufacturers in 2023

Figure 18. Global Halobetasol Propionate Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Halobetasol Propionate Players: Market Share by Revenue in 2023

Figure 20. Halobetasol Propionate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Halobetasol Propionate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Halobetasol Propionate Sales Market Share by Country (2019-2030)

Figure 23. North America Halobetasol Propionate Revenue Market Share by Country (2019-2030)

Figure 24. United States Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Halobetasol Propionate Sales Market Share by Country (2019-2030)

Figure 27. Europe Halobetasol Propionate Revenue Market Share by Country (2019-2030)

Figure 28. Germany Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Halobetasol Propionate Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Halobetasol Propionate Revenue Market Share by Region (2019-2030)

Figure 35. China Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Halobetasol Propionate Sales Market Share by Country (2019-2030)

Figure 43. Latin America Halobetasol Propionate Revenue Market Share by Country (2019-2030)

Figure 44. Mexico Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Halobetasol Propionate Sales Market Share by Country (2019-2030)

Figure 48. Middle East & Africa Halobetasol Propionate Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Halobetasol Propionate Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Halobetasol Propionate by Type (2019-2030)

Figure 53. Global Revenue Market Share of Halobetasol Propionate by Type (2019-2030)

Figure 54. Global Halobetasol Propionate Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Halobetasol Propionate by Application (2019-2030)

Figure 56. Global Revenue Market Share of Halobetasol Propionate by Application (2019-2030)

Figure 57. Global Halobetasol Propionate Price (US$/Unit) by Application (2019-2030)

Figure 58. Halobetasol Propionate Value Chain

Figure 59. Halobetasol Propionate Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Distributors Profiles

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Stainless Steel Medication Trolley Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18N15820

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Instant Molecular Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G15638

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Universal Cell Therapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14U15769

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Preclinical Toxicology Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1P15930

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions